Literature DB >> 8836183

The single-stranded DNA end binding site of p53 coincides with the C-terminal regulatory region.

G Selivanova1, V Iotsova, E Kiseleva, M Ström, G Bakalkin, R C Grafström, K G Wiman.   

Abstract

p53 is a transcription factor that binds double-stranded (ds) DNA in a sequence-specific manner. In addition, p53 can bind the ends of single-stranded (ss) DNA. We previously demonstrated that ssDNA oligonucleotides interact with the C-terminal domain of p53 and stimulate binding to internal segments of long ssDNA by the p53 core domain. Here we show that the p53 C-terminal domain can recognize staggered ss ends of dsDNA. We have mapped the binding site for ssDNA ends to residues 361-382 in human p53 using a p53 deletion mutant (p53-delta 30) lacking the 30 C-terminal amino acid residues and a series of 22mer peptides. The binding site for DNA ends coincides with a region previously implicated in regulation of sequence-specific DNA binding by the core domain. The interaction of the C-terminal regulatory domain with the ends of ssDNA or with the protruding ends of dsDNA stimulates both sequence-specific and non-specific DNA binding via the core domain. Electron microscopy demonstrated the simultaneous binding of p53 to dsDNA and a ssDNA end. These results suggest a model in which interaction of the p53 C-terminal tail with DNA ends generated after DNA damage causes activation of sequence-specific p53 DNA binding in vivo and may thus provide a molecular link between DNA damage and p53-mediated growth arrest and apoptosis.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8836183      PMCID: PMC146129          DOI: 10.1093/nar/24.18.3560

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  47 in total

1.  Tumor suppressor p53 is a direct transcriptional activator of the human bax gene.

Authors:  T Miyashita; J C Reed
Journal:  Cell       Date:  1995-01-27       Impact factor: 41.582

2.  p53 domains: identification and characterization of two autonomous DNA-binding regions.

Authors:  Y Wang; M Reed; P Wang; J E Stenger; G Mayr; M E Anderson; J F Schwedes; P Tegtmeyer
Journal:  Genes Dev       Date:  1993-12       Impact factor: 11.361

3.  p53 binds single-stranded DNA ends and catalyzes DNA renaturation and strand transfer.

Authors:  G Bakalkin; T Yakovleva; G Selivanova; K P Magnusson; L Szekely; E Kiseleva; G Klein; L Terenius; K G Wiman
Journal:  Proc Natl Acad Sci U S A       Date:  1994-01-04       Impact factor: 11.205

4.  Human p53 directs DNA strand reassociation and is photolabelled by 8-azido ATP.

Authors:  R Brain; J R Jenkins
Journal:  Oncogene       Date:  1994-06       Impact factor: 9.867

5.  The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots.

Authors:  N P Pavletich; K A Chambers; C O Pabo
Journal:  Genes Dev       Date:  1993-12       Impact factor: 11.361

6.  Crystal structure of a p53 tumor suppressor-DNA complex: understanding tumorigenic mutations.

Authors:  Y Cho; S Gorina; P D Jeffrey; N P Pavletich
Journal:  Science       Date:  1994-07-15       Impact factor: 47.728

7.  Allosteric activation of latent p53 tetramers.

Authors:  T R Hupp; D P Lane
Journal:  Curr Biol       Date:  1994-10-01       Impact factor: 10.834

8.  p53 oligomerization and DNA looping are linked with transcriptional activation.

Authors:  J E Stenger; P Tegtmeyer; G A Mayr; M Reed; Y Wang; P Wang; P V Hough; I A Mastrangelo
Journal:  EMBO J       Date:  1994-12-15       Impact factor: 11.598

9.  Conformational shifts propagate from the oligomerization domain of p53 to its tetrameric DNA binding domain and restore DNA binding to select p53 mutants.

Authors:  T D Halazonetis; A N Kandil
Journal:  EMBO J       Date:  1993-12-15       Impact factor: 11.598

10.  Cyclin G is a transcriptional target of the p53 tumor suppressor protein.

Authors:  K Okamoto; D Beach
Journal:  EMBO J       Date:  1994-10-17       Impact factor: 11.598

View more
  16 in total

1.  p53 C-terminal interaction with DNA ends and gaps has opposing effect on specific DNA binding by the core.

Authors:  S B Zotchev; M Protopopova; G Selivanova
Journal:  Nucleic Acids Res       Date:  2000-10-15       Impact factor: 16.971

2.  p53-mediated DNA renaturation can mimic strand exchange.

Authors:  D Jean; D Gendron; L Delbecchi; P Bourgaux
Journal:  Nucleic Acids Res       Date:  1997-10-15       Impact factor: 16.971

3.  Induced N- and C-terminal cleavage of p53: a core fragment of p53, generated by interaction with damaged DNA, promotes cleavage of the N-terminus of full-length p53, whereas ssDNA induces C-terminal cleavage of p53.

Authors:  A L Okorokov; F Ponchel; J Milner
Journal:  EMBO J       Date:  1997-10-01       Impact factor: 11.598

4.  Reciprocal interference between the sequence-specific core and nonspecific C-terminal DNA binding domains of p53: implications for regulation.

Authors:  M E Anderson; B Woelker; M Reed; P Wang; P Tegtmeyer
Journal:  Mol Cell Biol       Date:  1997-11       Impact factor: 4.272

5.  DNA damage-inducible phosphorylation of p53 at N-terminal sites including a novel site, Ser20, requires tetramerization.

Authors:  S Y Shieh; Y Taya; C Prives
Journal:  EMBO J       Date:  1999-04-01       Impact factor: 11.598

6.  Reciprocally regulated chromatin association of Cockayne syndrome protein B and p53 protein.

Authors:  Robert J Lake; Asjad Basheer; Hua-Ying Fan
Journal:  J Biol Chem       Date:  2011-08-18       Impact factor: 5.157

7.  Activation and autoregulation of DNA-PK from structured single-stranded DNA and coding end hairpins.

Authors:  S Soubeyrand; H Torrance; W Giffin; W Gong; C Schild-Poulter; R J Haché
Journal:  Proc Natl Acad Sci U S A       Date:  2001-07-31       Impact factor: 11.205

Review 8.  p53 and the CNS: tumors and developmental abnormalities.

Authors:  G Fulci; E G Van Meir
Journal:  Mol Neurobiol       Date:  1999-02       Impact factor: 5.590

9.  Reactivation of mutant p53 through interaction of a C-terminal peptide with the core domain.

Authors:  G Selivanova; L Ryabchenko; E Jansson; V Iotsova; K G Wiman
Journal:  Mol Cell Biol       Date:  1999-05       Impact factor: 4.272

Review 10.  New p53-based anti-cancer therapeutic strategies.

Authors:  K G Wiman
Journal:  Med Oncol       Date:  1998-12       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.